Polypod-like structured guanine-rich oligonucleotide aptamer as a selective and cytotoxic nanostructured DNA to cancer cells

References

• Zhu J, Huang H, Dong S, et al. Progress in aptamer-mediated drug delivery vehicles for cancer targeting and its implications in addressing chemotherapeutic challenges. Theranostics. 2014;4(9):931–944.
   PubMed Web of Science ®Google Scholar
• Reinemann C, Strehlitz B. Aptamer-modified nanoparticles and their use in cancer diagnostics and treatment. Swiss Med Wkly. 2014;144:w13908.
   PubMed Web of Science ®Google Scholar
• Ozalp VC, Eyidogan F, Oktem HA. Aptamer-gated nanoparticles for smart drug delivery. Pharmaceuticals. 2011;4(8):1137–1157.
   Google Scholar
• Ireson CR, Kelland LR. Discovery and development of anticancer aptamers. Mol Cancer Ther. 2006;5(12):2957–2962.
   PubMed Web of Science ®Google Scholar
• Bates PJ, Laber DA, Miller DM, et al. Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer. Exp Mol Pathol. 2009;86(3):151–164.
   PubMed Web of Science ®Google Scholar
• Bates PJ, Kahlon JB, Thomas SD, et al. Antiproliferative activity of G-rich oligonucleotides correlates with protein binding. J Biol Chem. 1999;274(37):26369–26377.
   PubMed Web of Science ®Google Scholar
• Lee KY, Kang H, Ryu SH, et al. Bioimaging of nucleolin aptamer-containing 5-(N-benzylcarboxyamide)-2′-deoxyuridine more capable of specific binding to targets in cancer cells. J Biomed Biotechnol. 2010;2010:168306.
   PubMedGoogle Scholar
• Borer RA, Lehner CF, Eppenberger HM, et al. Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell. 1989;56(3):379–390.
   PubMed Web of Science ®Google Scholar
• Ginisty H, Sicard H, Roger B, et al. Structure and functions of nucleolin. J Cell Sci. 1999;112:761–772.
   PubMed Web of Science ®Google Scholar
• Hovanessian AG, Soundaramourty C, Khoury DE, et al. Surface expressed nucleolin is constantly induced in tumor cells to mediate calcium-dependent ligand internalization. PLoS One. 2010;5(12):e15787.
   PubMed Web of Science ®Google Scholar
• Chen X, Kube DM, Cooper MJ, et al. Cell surface nucleolin serves as receptor for DNA nanoparticles composed of pegylated polylysine and DNA. Mol Ther. 2008;16(2):333–342.
   PubMed Web of Science ®Google Scholar
• Soundararajan S, Chen W, Spicer EK, et al. The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells. Cancer Res. 2008;68(7):2358–2365.
   PubMed Web of Science ®Google Scholar
• Soundararajan S, Wang L, Sridharan V, et al. Plasma membrane nucleolin is a receptor for the anticancer aptamer AS1411 in MV4-11 leukemia cells. Mol Pharmacol. 2009;76(5):984–991.
   PubMed Web of Science ®Google Scholar
• Reyes-Reyes EM, Šalipur FR, Shams M, et al. Mechanistic studies of anticancer aptamer AS1411 reveal a novel role for nucleolin in regulating Rac1 activation. Mol Oncol. 2015;9(7):1392–1405.
   PubMed Web of Science ®Google Scholar
• Nishikawa M, Rattanakiat S, Takakura Y. DNA-based nano-sized systems for pharmaceutical and biomedical applications. Adv Drug Deliv Rev. 2010;62(6):626–632.
   PubMed Web of Science ®Google Scholar
• Mohri K, Nishikawa M, Takahashi Y, et al. DNA nanotechnology-based development of delivery systems for bioactive compounds. Eur J Pharm Sci. 2014;58:26–33.
   PubMed Web of Science ®Google Scholar
• Mohri K, Nishikawa M, Takahashi N, et al. Design and development of nanosized DNA assemblies in polypod-like structures as efficient vehicles for immunostimulatory CpG motifs to immune cells. ACS Nano. 2012;6(7):5931–5940.
   PubMed Web of Science ®Google Scholar
• Uno S, Nishikawa M, Mohri K, et al. Efficient delivery of immunostimulatory DNA to mouse and human immune cells through the construction of polypod-like structured DNA. Nanomedicine. 2014;10(4):765–774.
   PubMed Web of Science ®Google Scholar
• Mohri K, Nagata K, Ohtsuki S, et al. Elucidation of the mechanism of increased activity of immunostimulatory DNA by the formation of polypod-like structure. Pharm Res. 2017;34(11):2362–2370.
   PubMed Web of Science ®Google Scholar
• Mohri K, Kusuki E, Ohtsuki S, et al. Self-assembling DNA dendrimer for effective delivery of immunostimulatory CpG DNA to immune cells. Biomacromolecules. 2015;16(4):1095–1101.
   PubMed Web of Science ®Google Scholar
• Nishikawa M, Ogawa K, Umeki Y, et al. Injectable, self-gelling, biodegradable, and immunomodulatory DNA hydrogel for antigen delivery. J Control Release. 2014;180:25–32.
   PubMed Web of Science ®Google Scholar
• Umeki Y, Mohri K, Kawasaki Y, et al. Induction of potent antitumor immunity by sustained release of cationic antigen from a DNA-based hydrogel with adjuvant activity. Adv Funct Mater. 2015;25(36):5758–5767.
   Web of Science ®Google Scholar
• Nishikawa M, Mizuno Y, Mohri K, et al. Biodegradable CpG DNA hydrogels for sustained delivery of doxorubicin and immunostimulatory signals in tumor-bearing mice. Biomaterials. 2011;32(2):488–494.
   PubMed Web of Science ®Google Scholar
• Bates PJ, Reyes-Reyes EM, Malik MT, et al. G-quadruplex oligonucleotide AS1411 as a cancer-targeting agent: uses and mechanisms. Biochim Biophys Acta Gen Subj. 2017;1861(5):1414–1428.
   PubMed Web of Science ®Google Scholar
• Zheng J, Zhu G, Li Y, et al. A spherical nucleic acid platform based on self-assembled DNA biopolymer for high-performance cancer therapy. ACS Nano. 2013;7(8):6545–6554.
   PubMed Web of Science ®Google Scholar
• Dam DH, Culver KS, Odom TW. Grafting aptamers onto gold nanostars increases in vitro efficacy in a wide range of cancer cell types. Mol Pharm. 2014;11(2):580–587.
   PubMedGoogle Scholar
• Dam DH, Lee RC, Odom TW. Improved in vitro efficacy of gold nanoconstructs by increased loading of G-quadruplex aptamer. Nano Lett. 2014;14(5):2843–2848.
   PubMed Web of Science ®Google Scholar
• Kang WJ, Ko MH, Lee DS, et al. Bioimaging of geographically adjacent proteins in a single cell by quantum dot-based fluorescent resonance energy transfer. Proteomics Clin Appl. 2009;3(12):1383–1388.
   PubMed Web of Science ®Google Scholar
• Charoenphol P, Bermudez H. Aptamer-targeted DNA nanostructures for therapeutic delivery. Mol Pharm. 2014;11(5):1721–1725.
   PubMedGoogle Scholar
• Xu X, Zhao Y, Lu H, et al. G4-tetra DNA duplex induce lung cancer cell apoptosis in A549 Cells. Nanoscale Res Lett. 2016;11(1):437.
   PubMedGoogle Scholar
• Wang X, Seeman NC. Assembly and characterization of 8-arm and 12-arm DNA branched junctions. J Am Chem Soc. 2007;129(26):8169–8176.
   PubMed Web of Science ®Google Scholar
• Takafuji Y, Jo J, Tabata Y. Simple PEG modification of DNA aptamer based on copper ion coordination for tumor targeting. J Biomater Sci Polym Ed. 2011;22(9):1179–1195.
   PubMed Web of Science ®Google Scholar
• Li J, Zheng H, Bates PJ, et al. Aptamer imaging with Cu-64 labeled AS1411: preliminary assessment in lung cancer. Nucl Med Biol. 2014;41(2):179–185.
   PubMed Web of Science ®Google Scholar
• Dapić V, Bates PJ, Trent JO, et al. Antiproliferative activity of G-quartet-forming oligonucleotides with backbone and sugar modifications. Biochemistry. 2002;41(11):3676–3685.
   PubMed Web of Science ®Google Scholar
• Choi EW, Nayak LV, Bates PJ. Cancer-selective antiproliferative activity is a general property of some G-rich oligodeoxynucleotides. Nucleic Acids Res. 2010;38(5):1623–1635.
   PubMed Web of Science ®Google Scholar
• Biyani M, Nishigaki K. Structural characterization of ultra-stable higher-ordered aggregates generated by novel guanine-rich DNA sequences. Gene. 2005;364:130–138.
   PubMed Web of Science ®Google Scholar
• Eder PS, DeVine RJ, Dagle JM, et al. Substrate specificity and kinetics of degradation of antisense oligonucleotides by a 3′ exonuclease in plasma. Antisense Res Dev. 1991;1(2):141–151.
   PubMedGoogle Scholar
• Mohri K, Takahashi N, Nishikawa M, et al. Increased immunostimulatory activity of polypod-like structured DNA by ligation of the terminal loop structures. J Control Release. 2012;163(3):285–292.
   PubMed Web of Science ®Google Scholar
• Ko HY, Choi KJ, Lee CH, et al. A multimodal nanoparticle-based cancer imaging probe simultaneously targeting nucleolin, integrin αvβ3 and tenascin-C proteins. Biomaterials. 2011;32(4):1130–1138.
   PubMed Web of Science ®Google Scholar
• Zavvar TS, Babaei M, Abnous K, et al. Synthesis of multimodal polymersomes for targeted drug delivery and MR/fluorescence imaging in metastatic breast cancer model. Int J Pharm. 2020;578:119091.
   PubMedGoogle Scholar
• Abnous K, Danesh NM, Ramezani M, et al. A smart ATP-responsive chemotherapy drug-free delivery system using a DNA nanostructure for synergistic treatment of breast cancer in vitro and in vivo. J Drug Target. 2020;28(7–8):852–859.
   PubMed Web of Science ®Google Scholar
• Liao ZX, Chuang EY, Lin CC, et al. An AS1411 aptamer-conjugated liposomal system containing a bubble-generating agent for tumor-specific chemotherapy that overcomes multidrug resistance. J Control Release. 2015;208:42–51.
   PubMed Web of Science ®Google Scholar
• Wu J, Song C, Jiang C, et al. Nucleolin targeting AS1411 modified protein nanoparticle for antitumor drugs delivery. Mol Pharm. 2013;10(10):3555–3563.
   PubMedGoogle Scholar
• Parekh P, Kamble S, Zhao N, et al. Immunotherapy of CD30-expressing lymphoma using a highly stable ssDNA aptamer. Biomaterials. 2013;34(35):8909–89017.
   PubMed Web of Science ®Google Scholar